|
WO2014041537A1
|
|
Protein kinase c (pkc) alpha inhibitors for treatment and prevention of toxicities caused by radiation
|
|
IL226134D0
|
|
Buffered ophthalmic compositions and methods of use thereof
|
|
US2013296224A1
|
|
Method for treatment of inflammatory disease and disorder
|
|
US2013296250A1
|
|
Method for treatment of psoriasis
|
|
AU2012216534A1
|
|
Method for treatment of inflammatory disease and disorder
|
|
CN104758921A
|
|
Buffered ophthalmic compositions and methods of use thereof
|
|
CN102724994A
|
|
Method for treatment of inflammatory disease and disorder
|
|
WO2010097788A2
|
|
Visfatin therapeutic agents for the treatment of acne and other conditions
|
|
NZ582556A
|
|
Pharmaceutical composition for treating wounds and related methods
|
|
CA2823372A1
|
|
Pharmaceutical composition for treating wounds and related methods
|
|
NZ566083A
|
|
Methods and compositions for prevention and treatment of diabetic and aged skin
|
|
IL173596D0
|
|
Pharmaceutical compositions and methods for accelerating wound healing
|
|
US2006258562A1
|
|
Methods and pharmaceutical compositions for healing wounds
|
|
CN102120031A
|
|
Pharmaceutical compositions and methods for accelerating wound healing
|
